6don MSNOpinion
I was a doctor caring for Alzheimer’s patients. At 57, I became one. Here’s what’s next
Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...
HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...
Morning Overview on MSN
New “intrabodies” could lead to treatments for MND and Alzheimer’s
Researchers are engineering a new class of miniature antibodies, called intrabodies, that can operate inside living cells to ...
Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new ...
New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...
GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...
In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...
A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...
Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...
New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein buildup.
Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment. TOKYO and CAMBRIDGE, Mass., March 20, 2026 ...
The findings could help clinicians use neuropsychiatric symptoms to prepare patients and families for a type of dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results